Curcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptors

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Nejati Koshki, Kazem ^a   Akbarzadeh, Abolfazl ^a   Pourhassan Moghaddam, Mohammad ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Curcumin; Leptin; T47D cell line

Indexed keywords

CURCUMIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LEPTIN; MESSENGER RNA; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HORMONE RELEASE; HUMAN; HUMAN CELL; IC50; MTT ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANTINEOPLASTIC ACTIVITY; BREAST CANCER CELL LINE; CANCER INHIBITION; CELL CULTURE; CYTOTOXICITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 84928390763     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-14-66     Document Type: Article

References (54)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012,62(1):10-29. 10.3322/caac.20138.
2. Vona-Davis L, Rose DP: Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007,14(2):189-206. 10.1677/ERC-06-0068.
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994,372(6505):425-432. 10.1038/372425a0.
4. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat regulation. Nature 1996,380(6576):677. 10.1038/380677a0.
5. Fantuzzi G, Faggioni R: Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000,68(4):437-446.
6. Löffler S, Aust G, Köhler U, Spanel-Borowski K: Evidence of leptin expression in normal and polycystic human ovaries. Mol Hum Reprod 2001,7(12):1143-1149. 10.1093/molehr/7.12.1143.
7. Soyupek S, Armağan A, Serel TA, Hoşcan MB, Perk H, Karaöz E, Candir O: Leptin expression in the testicular tissue of fertile and infertile men. Arch Androl 2005,51(3):239-246. 10.1080/01485010590919666.
8. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K: Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997,3(9):1029-1033. 10.1038/nm0997-1029.
9. Morroni M, De Matteis R, Palumbo C, Ferretti M, Villa I, Rubinacci A, Cinti S, Marotti G: In vivo leptin expression in cartilage and bone cells of growing rats and adult humans. J Anat 2004,205(4):291-296. 10.1111/j.0021-8782.2004.00333.x.
10. Solberg R, Aas V, Thoresen GH, Kase ET, Drevon CA, Rustan AC, Reseland JE: Leptin expression in human primary skeletal muscle cells is reduced during differentiation. J Cell Biochem 2005,96(1):89-96. 10.1002/jcb.20521.
11. Mix H, Widjaja A, Jandl O, Cornberg M, Kaul A, Göke M, Beil W, Kuske M, Brabant G, Manns MP, Wagner S: Expression of leptin and leptin receptor isoforms in the human stomach. Gut 2000,47(4):481-486. 10.1136/gut.47.4.481.
12. Oda A, Taniguchi T, Yokoyama M: Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001,47(3):141-150.
13. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP: Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001,121(1):79-90. 10.1053/gast.2001.25490.
14. Liu Z, Uesaka T, Watanabe H, Kato N: High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol 2001,19(5):1009-1014.
15. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R, Giudicelli Y: Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2002,293(1):622-628. 10.1016/S0006-291X(02)00205-X.
16. Laud K, Gourdou I, Pessemesse L, Peyrat JP, Djiane J: Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002,188(1-2):219-226.
17. Hu X, Juneja SC, Maihle NJ, Cleary MP: Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002,94(22):1704-1711. 10.1093/jnci/94.22.1704.
18. Tartaglia LA: The leptin receptor. J Biol Chem 1997,272(10):6093-6096. 10.1074/jbc.272.10.6093.
19. Ishikawa M, Kitayama J, Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004,10(13):4325-4331. 10.1158/1078-0432.CCR-03-0749.
20. Koda M, Sulkowska M, Kanczuga-Koda L, Jarzabek K, Sulkowski S: Expression of leptin and its receptor in female breast cancer in relation with selected apoptotic markers. Folia Histochem Cytobiol 2007,45(Suppl 1):S187-S191.
21. Shin JH, Hur JY, Seo HS, Jeong YA, Lee JK, Oh MJ, Kim T, Saw HS, Kim SH: The ratio of estrogen receptor alpha to estrogen receptor beta in adipose tissue is associated with leptin production and obesity. Steroids 2007,72(6-7):592-599.
22. Shehzad A, Wahid F, Lee YS: Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 2010,343(9):489-499. 10.1002/ardp.200900319.
23. Pourhassan M, Zarghami N, Rahmati M, Alibakhshi A, Ranjbari R: The inhibitory effect of Curcuma longa extract on telomerase activity in A549 lung cancer cell line. Afr J Biotechnol 2010,9(6):912-919.
24. Garofalo C, Surmacz E: Leptin and cancer. J Cell Physiol 2006,207(1):12-22. 10.1002/jcp.20472.
25. Gonzalez RR, Watters A, Xu Y, Singh UP, Mann DR, Rueda BR, Penichet ML: Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res 2009,11(3):R36. 10.1186/bcr2321.
26. Peters JH, Simasko SM, Ritter RC: Leptin analog antagonizes leptin effects on food intake and body weight but mimics leptin-induced vagal afferent activation. Endocrinology 2007, 148:2878-2885. 10.1210/en.2006-1320.
27. Fazeli M, Zarkesh-Esfahani H, Wu Z, Maamra M, Bidlingmaier M, Pockley AG, Watson P, Matarese G, Strasburger CJ, Ross RJ: Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods 2006,312(1-2):190-200.
28. Ray A, Cleary MP: Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets 2010,14(4):443-451. 10.1517/14728221003716466.
29. Shehzad A, Lee J, Lee YS: Curcumin in various cancers. Biofactors 2013, 1:56-68.
30. Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB: Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 2009, 125:2187-2197. 10.1002/ijc.24593.
31. Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R: Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Mol Cancer Ther 2009,8(6):1606-1612. 10.1158/1535-7163.MCT-08-1152.
32. Yi KW, Shin JH, Seo HS, Lee JK, Oh MJ, Kim T, Saw HS, Kim SH, Hur JY: Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3 T3-L1 adipocytes. Obesity (Silver Spring) 2008,16(11):2393-2399. 10.1038/oby.2008.389.
33. O'Neil JS, Burow ME, Green AE, McLachlan JA, Henson MC: Effects of estrogen on leptin gene promoter activation in MCF-7 breast cancer and JEG-3 choriocarcinoma cells: selective regulation via estrogen receptors alpha and beta. Mol Cell Endocrinol 2001,176(1-2):67-75.
34. Nejati-Koshki K, Zarghami N, Pourhassan-Moghaddam M, Rahmati-Yamchi M, Mollazade M, Nasiri M, Esfahlan RJ, Barkhordari A, Tayefi-Nasrabadi H: Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology 2012,64(6):719-726. 10.1007/s10616-012-9452-3.
35. 4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine 2012, 7:511-526.
36. Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Amir Mohammad G, Khaksar Khiabani H, Soodabeh D: Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ 2012, 5:13-25.
37. Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S: Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol 2012, 10:46-58. 10.1186/1477-3155-10-46.
38. Zohreh E, Nosratollah Z, Manoutchehr K, Soumaye A, Abolfazl A, Mohammad R, Zohreh Mohammad T, Kazem N-K: Inhibition of hTERT Gene Expression by Silibinin-Loaded PLGA-PEG-Fe3O4 in T47D Breast Cancer Cell Line. BioImpacts 2013,3(2):67-74.
39. Davaran S, Alimirzalu S, Nejati-Koshki K, Hamid Tayefi N, Abolfazl A, Amir Ahmad K, Mojtaba A, Somayeh A: Synthesis and study of physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly (Nisopropylacrylamide) for anti-cancer drugs delivery. Asian Pac J Cancer Prev 2014,15(1):049-054. 10.7314/APJCP.2014.15.1.49.
40. Rogaie R-S, Nosratollah Z, Abolfazl B, Akram E, Abolfazl A, Mustafa R-T: Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft 2013, 2:13-18. 10.4236/soft.2013.23004.
41. Nejati-Koshki K, Akbarzadeh A, pourhasan-Moghadam M, woo joo S: Inhibition of leptin and leptin receptor gene expression by silibinin- curcumin combination. Asian Pac J Cancer Prev 2013,14(11):6595-6599. 10.7314/APJCP.2013.14.11.6595.
42. Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, Alizadeh E, Barkhordari A, Tozihi M, Kordi S: Study of inhibitory effect of ß-Cyclodextrin-HelenalinComplex on HTERT Gene Expression in T47D breast cancer cell line by Real TimeQuantitative PCR (q-PCR). Asian Pac J Cancer Prev 2013,14(11):6949-6953. 10.7314/APJCP.2013.14.11.6949.
43. Mollazade M, Nejati-Koshki K, Abolfazl A, Younes H, Zarghami N, Sang Woo J: PAMAM Dendrimers arugment inhibitory effect of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev 2013,14(11):6925-6928. 10.7314/APJCP.2013.14.11.6925.
44. Davaran S, Rezaei A, Alimohammadi S, Amir Ahmad K, Kazem N-K, Hamid Tayefi N, Abolfazl A: Synthesis and Physicochemical Characterization of Biodegradable star-shaped poly lactide-co-glycolide- ß -cyclodextrin copolymer Nanoparticles Containing Albumin. Adv Nanoparticles 2014, 3:14-22. 10.4236/anp.2014.31003.
45. Davaran S, Abolfazl Akbarzadeh1, Kazem N-K, Somayeh A, Mahmoud Farajpour G, Mahsa Mahmoudi S, Akbar R, Amir Ahmad K: In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release. J Encapsulation Adsorption Sci 2013, 3:108-115. 10.4236/jeas.2013.34013.
46. Nasiri M, Zarghami N, Koshki KN, Mollazadeh M, Moghaddam MP, Yamchi MR, Esfahlan RJ, Barkhordari A, Alibakhshi A: Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pac J Cancer Prev 2013,14(6):3449-3453. 10.7314/APJCP.2013.14.6.3449.
47. Abolfazl A, Samiei M, Soodabeh D: Magnetic nanoparticles: preparation, physical properties and applications in biomedicine. Nanoscale Res Lett 2012, 7:144-157. 10.1186/1556-276X-7-144.
48. Alireza V, Haleh M, Mohammad S, Samad Mussa F, Nosratollah Z, Mohammad K, Abolfazl A, Soodabeh D: Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett 2012, 7:276. 10.1186/1556-276X-7-276.
49. Abolfazl A, Rogaie R-S, Soodabeh D, Sang Woo J, Nosratollah Z, Younes H, Mohammad S, Mohammad K, Kazem N-K: Liposome: classification, preparation, and applications. Nanoscale Res Lett 2013, 8:102. 10.1186/1556-276X-8-102.
50. Mohammad P-M, Mohammad R-Y, Abolfazl A, Hadis D, Kazem N-K, Younes H, Sang Woo J: Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett 2013, 8:485. 10.1186/1556-276X-8-485.
51. Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, Mohammad Taheri Z, Nejati-Koshki K: Inhibition of hTERT Gene Expression by Silibinin-Loaded PLGA-PEG-Fe3O4 in T47D Breast Cancer Cell Line. Bioimpacts 2013,3(2):67-74.
52. Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW: Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 2013,8(1):485. 10.1186/1556-276X-8-485.
53. Esfahlan RJ, Zarghami N, Esfahlan AJ, Mollazadeh M, Nejati K, Nasiri M: Basic of DNA biosensors and cancer diagnosis. The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERß) Gene Expression in Breast Cancer Patients. Breast Cancer (Auckl) 2011, 5:227-337.
54. Mirakabad FST, Akbarzadeh A, Zarghami N, Zeighamian V, Rahimzadeh A, Alimohammadi S: PLGA-Cased nanoparticles as cancer drug delivery systems. APJCP Asian Pac J Cancer Prev 2014,15(1):517-535.